A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.
Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.
Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia.
Expert Q&A compares the effects of insulin degludec and insulin glargine U100 in patients with type 1 and type 2 diabetes.
Hypoglycemic episodes, moderate or severe, can effectively and efficiently be managed by nasal glucagon in adult patients with type 1 diabetes.
A single session of HIIT can "rapidly reduce" awareness of hypoglycemia in patients with type 1 diabetes.
A 37-year-old woman presented to the emergency department with recurrent dizziness following her recent pregnancy.
A voluntary recall was announced for one specific lot of 25% dextrose injection, USP (infant).
Researchers identified hypoglycemia as an "under-recognized" risk factor for death and CVD in people with type 2 diabetes.
Two diabetes associations are calling for more standard definitions of hypoglycemia to improve information on risk garnered during clinical trials.
For patients with type 1 diabetes, the incidence of hospitalization for hypoglycemia decreased over time in Denmark, with an 8.4% annual decrease.
Hospitalized patients who experience hypoglycemia are at an increased risk for short-term and long-term mortality.
For individuals with type 1 diabetes, liraglutide therapy does not affect the rate of gastric emptying during hypoglycemia.
A brief, partly web-based educational intervention, HypoAware, is beneficial for reducing severe hypoglycemic episodes and improving hypoglycemia awareness compared with usual care.
A patient came to the clinic to discuss her dizzy spells 4 years after her Roux-en-Y gastric bypass surgery.
Neonates born to mothers exposed to beta-blockers at the time of delivery have increased risk of neonatal hypoglycemia and bradycardia.
Of the newer generation sulfonylureas, gliclazide is associated with the lowest risk of hypoglycemia when added to metformin.
Glucagon should be recognized as a lifesaver for hypoglycemia and a major treatment for diabetes.
The risk of hypoglycemia is 5 times higher for diabetes patients with stage 4 or 5 chronic kidney disease (CKD) who currently use a sulfonylurea vs metformin.
Gastric bypass surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published in Diabetes.
Patients were highly confident in their dogs' ability, but data demonstrated poor predictive value vs CGM.
Patients using the electronic system had lower rates of hypoglycemia and less severe hypoglycemia.
Low bedtime glucose and daytime physical activity increase the risk for nocturnal hypoglycemia.
Sleep deprivation did not worsen cognitive impairment in type 1 diabetes, but prolonged post-hypoglycemia recovery.
Type 2 diabetes patients treated with combination insulin therapy had improved glucose control that was on par with up-titration of basal insulin.
Weight-based insulin doses were associated with less hypoglycemia for patients weighing less than 95 kg.
Black race, severe hypoglycemia, and insulin use were linked to failure to reach HbA1c targets in the ACCORD trial.
Intranasal glucagon was effective in treating insulin-induced hypoglycemia in type 1 diabetes.
Taking warfarin with a sulfonylurea like glipizide or glimepiride may increase risk for hospitalization.
In type 2 diabetes, peglispro was also tied to increased triglycerides, aminotransferases, and liver fat content.
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Improving Vascular Function in Pediatric T1D With Metformin
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation